
In 2008, the FDA approved daily Repetitive Transcranial Magnetic Stimulation (rTMS) for treating depression. Lots of research since then, (some BBRF funded) has now expanded what we know and improved how we use TMS. This talk will cover the latest updates for depression (accelerated forms, new pulse frequencies, maintenance treatment) as well as rTMS in other diseases, not yet FDA approved, like OCD, substance abuse, and autism.
Watch webinar recording:
Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.
Presentation
Presented by
Moderated by